1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cerebrospinal Fluid Management - Pipeline Review, 2015

Cerebrospinal Fluid Management - Pipeline Review, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 65 pages

Cerebrospinal Fluid Management - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Cerebrospinal Fluid Management - Pipeline Review, 2015" provides an overview of Cerebrospinal Fluid Management products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebrospinal Fluid Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cerebrospinal Fluid Management products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cerebrospinal Fluid Management products and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cerebrospinal Fluid Management products under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Cerebrospinal Fluid Management - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
2 Introduction 7
2.1 Cerebrospinal Fluid Management Overview 7
3 Products under Development 8
3.1 CSF Management - Pipeline Products by Stage of Development 8
3.2 CSF Management - Pipeline Products by Segment 9
3.3 CSF Management - Pipeline Products by Territory 10
3.4 CSF Management - Pipeline Products by Regulatory Path 11
3.5 CSF Management - Pipeline Products by Estimated Approval Date 12
3.6 CSF Management - Ongoing Clinical Trials 13
4 CSF Management - Pipeline Products under Development by Companies 14
4.1 CSF Management Companies - Pipeline Products by Stage of Development 14
4.2 CSF Management - Pipeline Products by Stage of Development 15
5 CSF Management Companies and Product Overview 17
5.1 Aqueduct Neurosciences Company Overview 17
5.1.1 Aqueduct Neurosciences Pipeline Products and Ongoing Clinical Trials Overview 17
5.2 Arkis BioSciences Company Overview 20
5.2.1 Arkis BioSciences Pipeline Products and Ongoing Clinical Trials Overview 20
5.3 Beckersmith Medical, Inc. Company Overview 21
5.3.1 Beckersmith Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
5.4 Biosan Medical Ltd. Company Overview 22
5.4.1 Biosan Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 22
5.5 Ceremed, Inc. Company Overview 23
5.5.1 Ceremed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
5.6 CSF Therapeutics, Inc. Company Overview 24
5.6.1 CSF Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 24
5.7 Georgia Institute of Technology Company Overview 25
5.7.1 Georgia Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 25
5.8 H-Cubed Inc. Company Overview 27
5.8.1 H-Cubed Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
5.9 Integra LifeSciences Holdings Corporation Company Overview 28
5.9.1 Integra LifeSciences Holdings Corporation Pipeline Products and Ongoing Clinical Trials Overview 28
5.10 InVivo Therapeutics Corporation Company Overview 33
5.10.1 InVivo Therapeutics Corporation Pipeline Products and Ongoing Clinical Trials Overview 33
5.11 Kerecis ehf Company Overview 36
5.11.1 Kerecis ehf Pipeline Products and Ongoing Clinical Trials Overview 36
5.12 Microbot Medical, Ltd. Company Overview 37
5.12.1 Microbot Medical, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 37
5.13 Nanonerve Inc. Company Overview 39
5.13.1 Nanonerve Inc. Pipeline Products and Ongoing Clinical Trials Overview 39
5.14 NexGen Medical Systems, Inc. Company Overview 40
5.14.1 NexGen Medical Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
5.15 Sree Chitra Tirunal Institute for Medical Sciences and Technology Company Overview 41
5.15.1 Sree Chitra Tirunal Institute for Medical Sciences and Technology Pipeline Products and Ongoing Clinical Trials Overview 41
5.16 System Science Inc. Company Overview 42
5.16.1 System Science Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.17 University Hospital Zurich Company Overview 44
5.17.1 University Hospital Zurich Pipeline Products and Ongoing Clinical Trials Overview 44
5.18 University of Colorado Company Overview 45
5.18.1 University of Colorado Pipeline Products and Ongoing Clinical Trials Overview 45
5.19 University of Rochester Company Overview 46
5.19.1 University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 46
5.20 University of South Florida Company Overview 47
5.20.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 47
5.21 University of Wisconsin Madison Company Overview 49
5.21.1 University of Wisconsin Madison Pipeline Products and Ongoing Clinical Trials Overview 49
5.22 Vivonics, Inc. Company Overview 52
5.22.1 Vivonics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 52
5.23 Wayne State University Company Overview 54
5.23.1 Wayne State University Pipeline Products and Ongoing Clinical Trials Overview 54
6 CSF Management- Recent Developments 55
7 Appendix 62
7.1 Methodology 62
7.2 About GlobalData 64
7.3 Contact Us 64
7.4 Disclaimer 65

1.1 List of Tables
Table 1: CSF Management - Pipeline Products by Stage of Development 8
Table 2: CSF Management - Pipeline Products by Segment 9
Table 3: CSF Management - Pipeline Products by Territory 10
Table 4: CSF Management - Pipeline Products by Regulatory Path 11
Table 5: CSF Management - Pipeline Products by Estimated Approval Date 12
Table 6: CSF Management - Ongoing Clinical Trials 13
Table 7: CSF Management Companies - Pipeline Products by Stage of Development 14
Table 8: CSF Management - Pipeline Products by Stage of Development 15
Table 9: Aqueduct Neurosciences Pipeline Products and Ongoing Clinical Trials Overview 17
Table 10: Smart External Drainage System - Product Status 18
Table 11: Smart External Drainage System - Product Description 18
Table 12: Smart Shunt - Product Status 19
Table 13: Smart Shunt - Product Description 19
Table 14: Arkis BioSciences Pipeline Products and Ongoing Clinical Trials Overview 20
Table 15: AutoShunt - Product Status 20
Table 16: AutoShunt - Product Description 20
Table 17: Beckersmith Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
Table 18: FlowSafe - Product Status 21
Table 19: FlowSafe - Product Description 21
Table 20: Biosan Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 22
Table 21: Ventritek105 - Product Status 22
Table 22: Ventritek105 - Product Description 22
Table 23: Ceremed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
Table 24: Dural Repair System - Product Status 23
Table 25: Dural Repair System - Product Description 23
Table 26: CSF Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 24
Table 27: CSF Therapeutic Device - Product Status 24
Table 28: CSF Therapeutic Device - Product Description 24
Table 29: Georgia Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 25
Table 30: Hydrocephalus Shunt - Product Status 26
Table 31: Hydrocephalus Shunt - Product Description 26
Table 32: H-Cubed Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 33: Ambulatory System For Hydrocephalus Shunt - Product Status 27
Table 34: Ambulatory System For Hydrocephalus Shunt - Product Description 27
Table 35: Integra LifeSciences Holdings Corporation Pipeline Products and Ongoing Clinical Trials Overview 28
Table 36: Hydrocephalic Shunt - Product Status 29
Table 37: Hydrocephalic Shunt - Product Description 29
Table 38: Next Generation DuraGen - Product Status 30
Table 39: Next Generation DuraGen - Product Description 30
Table 40: Next Generation DuraSeal - Product Status 31
Table 41: Next Generation DuraSeal - Product Description 31
Table 42: Ventricular Drainage Device - Product Status 32
Table 43: Ventricular Drainage Device - Product Description 32
Table 44: InVivo Therapeutics Corporation Pipeline Products and Ongoing Clinical Trials Overview 33
Table 45: DuraGraft - Product Status 33
Table 46: DuraGraft - Product Description 33
Table 47: InVivo Therapeutics Corporation - Ongoing Clinical Trials Overview 34
Table 48: DuraGraft - A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG) 35
Table 49: Kerecis ehf Pipeline Products and Ongoing Clinical Trials Overview 36
Table 50: Kerecis Omega3 Dura - Product Status 36
Table 51: Kerecis Omega3 Dura - Product Description 36
Table 52: Microbot Medical, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 53: Microbot Self-Cleaning Shunt (SCS) device - Product Status 37
Table 54: Microbot Self-Cleaning Shunt (SCS) device - Product Description 38
Table 55: Nanonerve Inc. Pipeline Products and Ongoing Clinical Trials Overview 39
Table 56: Nanofibrous Dural Substitute - Product Status 39
Table 57: Nanofibrous Dural Substitute - Product Description 39
Table 58: NexGen Medical Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 59: EViTAR FLOWMETER - Product Status 40
Table 60: EViTAR FLOWMETER - Product Description 40
Table 61: Sree Chitra Tirunal Institute for Medical Sciences and Technology Pipeline Products and Ongoing Clinical Trials Overview 41
Table 62: Bovine Pericardium - Dura Substitute - Product Status 41
Table 63: Bovine Pericardium - Dura Substitute - Product Description 41
Table 64: System Science Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 65: Acute Cerebrospinal Fluid Monitor And Control System - Product Status 42
Table 66: Acute Cerebrospinal Fluid Monitor And Control System - Product Description 42
Table 67: Implantable Cerebrospinal Fluid Monitor And Control System - Product Status 43
Table 68: Implantable Cerebrospinal Fluid Monitor And Control System - Product Description 43
Table 69: University Hospital Zurich Pipeline Products and Ongoing Clinical Trials Overview 44
Table 70: SmartShunt - Product Status 44
Table 71: SmartShunt - Product Description 44
Table 72: University of Colorado Pipeline Products and Ongoing Clinical Trials Overview 45
Table 73: Neural Shunt - Product Status 45
Table 74: Neural Shunt - Product Description 45
Table 75: University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 46
Table 76: Catheterless Shunt System - Product Status 46
Table 77: Catheterless Shunt System - Product Description 46
Table 78: University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 47
Table 79: Shunt Catheter System With Inline Filter - Product Status 47
Table 80: Shunt Catheter System With Inline Filter - Product Description 47
Table 81: Sonic Window Cranioplasty Implant - Product Status 48
Table 82: Sonic Window Cranioplasty Implant - Product Description 48
Table 83: University of Wisconsin Madison Pipeline Products and Ongoing Clinical Trials Overview 49
Table 84: Gravity And Pressure Controlled Valve System - Product Status 50
Table 85: Gravity And Pressure Controlled Valve System - Product Description 50
Table 86: Hydrocephalus Stent - Product Status 51
Table 87: Hydrocephalus Stent - Product Description 51
Table 88: Vivonics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 52
Table 89: Micro Fabricated Implantable Flowmeter - Cerebrospinal Fluid (CSF) Shunt - Product Status 52
Table 90: Micro Fabricated Implantable Flowmeter - Cerebrospinal Fluid (CSF) Shunt - Product Description 53
Table 91: Wayne State University Pipeline Products and Ongoing Clinical Trials Overview 54
Table 92: Programmable Antisiphon Shunt System - Product Status 54
Table 93: Programmable Antisiphon Shunt System - Product Description 54
Table 94: Glossary 63

1.2 List of Figures
Figure 1: CSF Management - Pipeline Products by Stage of Development 8
Figure 2: CSF Management - Pipeline Products by Segment 9
Figure 3: CSF Management - Pipeline Products by Territory 10
Figure 4: CSF Management - Pipeline Products by Regulatory Path 11
Figure 5: CSF Management - Pipeline Products by Estimated Approval Date 12
Figure 6: CSF Management - Ongoing Clinical Trials 13

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.